EBV infection of T cells: Potential role in malignant transformation

Seminars in Cancer Biology

Volumn 7, Issue 4, 1996, Pages 197-207

  Kelleher, Colm A ^a   Dreyfus, David H ^a   Jones, James F ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Cancer; EBV; Linear configuration; Thymoctes; ZEBRA

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; VIRUS RECEPTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MONONUCLEOSIS; NONHUMAN; ONCOGENE; PROMOTER REGION; T LYMPHOCYTE; THYMOCYTE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION;

EID: 0030221498     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0027     Document Type: Article

References (69)

1. 1. Henle G, Henle W, Diehl W (1968) Relation of Burkitts's tumour associated herpes-type virus with infectious mononucleosis. Proc Natl Acad Sci USA 59:94-101
2. 2. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitts lymphoma. Lancet i:702-703
3. 3. Saemundsen AK, Purtillo DT, Sakamoto K, Sullivan JL, Synderholm AC, Hanto D, Simmons R, Anveret M, Collins R, Klein G (1981) Documentation of Epstein-Barr virus infection in immunodeficient patients with life threatening lymphproliferative diseases by Epstein-Barr virus complementary RNA/ DNA and viral DNA/ DNA hybridization. Cancer Res 41:4237-4242
4. 4. Purtillo D, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S (1982) Epstein-Barr virus induced diseases in boys with X-linked lymphproliferative syndrome (XLP). Update on studies of the registry. Am J Med 73:49-56
5. 5. Hanto DW, Gali-Peczalska KJ, Arthur DC, Balfour HH, McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical pathologic, and virologic findings and implications for therapy. Ann Surg 198:356-369
6. 6. Hamilton-Dutoit SJ, Pallesen G, Karkov J, Skinhoj P, Franzmann M, Pedersen C (1989) Identification of EBV-DNA in tumor cells of AIDS related lymphomas by in situ hybridisation. Lancet i:554-555
7. 7. Young LS, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080-1085
8. 8. Weiss LM, Movahed AM, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506
9. 9. Raab-Traub N, Flynn K, Pearson G, Huang A, Levine P, Lanier A, Pagano JS (1987) The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA Int J Cancer 39:25-29
10. 10. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM (1991) Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid proliferation. Am J Pathol 139:469-474
11. 11. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein Proc Nat Acad Sci 91:9131-9135
12. 12. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciatto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J (1988) T-cell lymphoma containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med 318:733-741
13. 13. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CL, Cheng AL, Kadin ME, Chen JY (1991) Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 77:799-808
14. 14. Su IJ, Lin KH, Chen CL, Tien HF, Hsieh HC, Lin DT, Chen JY (1990) Epstein-Barr virus associated peripheral T cell lymphoma of the activated CD8 phenotype. Cancer 66:2557-2562
15. 15. Chen C-L, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N (1993) Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T cell lymphomas. J Virol 67:6303-6308
16. 16. Tomita Y, Ohsawa M, Mishiro Y, Kubo T, Maeshiro N, Kojya S, Noda Y, Aosasa K (1995) The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino nasal region from the Osaka and Okinawa districts of Japan. Lab Invest 73:190-196
17. 17. Peh SC, Sandvej K, Pallesen G (1995) Epstein-Barr virus (EBV) in Malaysian upper-aerodigestive tract lymphoma; incidence and subtype. Int J Cancer 61:327-332
18. 18. deBruin PC, Jiwa NM, Oudejans JJ, Radaszkiewicz T, Meijer CJ (1995) Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy pathological features, and immunophenotype. Am J Pathol 146:861-867
19. 19. Grant JW, Isaacson PG (1992) Primary central nervous system lymphoma. Brain Pathol 2:97-109
20. 20. Peris K, Niedermeyer H, Cerroni L, Radaskiewicz T, Chimenti S, Hoffer H (1994) Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas. Arch Derm Res 286:364-368
21. 21. Cho KH, Oh JK, Kim CW, Heo DS, Kim ST (1995) Peripheral T cell lymphomas involving subcutaneous tissue. Br J Derm 132:290-295
22. 22. Borisch B, Caoni M, Hurwitz N, Dommann-Scherrer C, Odermatt B, Waelti E, Laeng RH, Kraft R, Laissue J. (1993) Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy. Int J Cancer 55:748-752
23. 23. Shore A, Dosch HM, Gelfand EW (1979) Expression and modulation of C3 receptors during early T-cell ontogeny. Cell Immunol 45:157-166
24. 24. Shevach E, Edelson R, Frank M, Lutzner M, Green I (1974) Proc Natl Acad Sci USA 71:863-866
25. 25. Tsoukas CD, Lambris JD (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18:1299-1302
26. 26. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD (1991) Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971-980
27. 27. Kaufman-Paterson RL, Kelleher C, Amankonah TD, Streib JE, Jones JF, Gelfand EW (1995) Activation of human thymocytes after infection with EBV. J Immunol 154:1440-1449
28. 28. Fischer E, Delibrias C, Kazatchkine MD (1991) Expression of CR2 (the C3dg/ EBV receptor, CD21 on normal human peripheral blood T lymphocytes. J Immunol 146:865-869
29. 29. Kaufman-Paterson RL, Kelleher CA, Amankonah TD, Streib JE, Xu JW, Jones JF, Gelfand EW (1995) Model of EBV infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T lymphoblastic cell line HPB-ALL. Blood 85:456-464
30. 30. Kelleher CA, Kaufmann-Paterson R, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW (1995) Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208:685-695
31. 31. Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:863-889
32. 32. Sato H, Takimoto S, Tanaka J, Raab-Traub N (1990) Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. J Virol 64:5295-5300
33. 33. Hurley EA, Thorley-Lawson DA (1979) B cell activation and the establishment of Epstein-Barr latency. J Exp Med 168:2059-2075
34. 34. Alfieri C, Birkenbach M, Kieff E (1991) Early events in Epstein-Barr virus of human B lymphocytes. Virology 181:595-608
35. 35. Asada H, Okada N, Hashimoto K, Yamanishi K, Sairenji T, Hirota S, Nomura S, Kitamura Y, Yoshikawa K (1994) Establishment and characterisation of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia. Leukemia 8:1415-1423
36. 36. Dreyfus DH, Kelleher CA, Jones JF, Gelfand EW (1996) Epstein-Barr virus Infection of T cells: Implications for altered T-lymphocyte activation, repertoire development and autoimmunity. Immunol Rev, in press
37. 37. Miller G (1990) In Epstein-Barr Virus, Biology, Pathogenesis and Medical Aspects (Field BNB, Knipe DM eds) 2nd Ed. New York, Raven Press
38. 38. Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA 82:4085-4089
39. 39. Manet E, Gruffat H, Trescol-Biemont MC, Moreno N, Chambard P, Giot JF, Sargeant A (1989) Epstein-Barr bicistronic mRNAs generated by facultative splicing code for two transcriptional transactivators. EMBO J 8:1819-1826
40. 40. Furnari FB, Zacny V, Quinlivan EB, Kenney S, Pagano J (1994) RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J Virol 68:1827-1836
41. 41. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 187:189-201
42. 42. Smith TJ, Terada N, Robinson C, Gelfand EW (1993) Acute infectious mononucleosis stimulates the selective expression/ expansion of Vβ6.1-3 and Vβ7 T cells. Blood 81:1521-1526
43. 43. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE (1989) EBV gene expression in an NPC related tumor. EMBO J 8:2639-2651
44. 44. Lear AF, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB (1992) The Epstein-Barr virus (EBV) nuclear antigen 1 Bam H1 F promoter is activated on entry of EBV transformed B cells into the lytic cycle. J Virol 66:7461-7468
45. 45. Koizumi S, Zhang XK, Imai S, Sugiura M, Osvi N, Osata T (1992) Infection of the HTLV-1 harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology 188:859-863
46. 46. Tierney RJ, Steven N, Young LS, Rickinson AB (1994) Epstein-Barr latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374-7385
47. 47. Anagnostopolous I, Hummel M, Kreschel C, Stein H (1995) Morphology, immunophenotype and distribution of latently and/ or productively Epstein-Barr virus infected cells in acute infectious mononucleosis: implications for interindividual infection route of Epstein-Barr virus. Blood 85:744-750
48. 48. Baumgarten E, Herbst H, Scmitt M, Seeger KH, Schulte-Overberg U, Henze G (1994) Life threatening infectious mononucleosis: it is correlated with virus induced T cell proliferation. Clin Infect Diseases 19:152-156
49. 49. Knox PG, Young LS (1995) Epstein-Barr virus infection of CR-2 transfected epithelial cells reveals the presence of MHC class II on the virion. Virology 213:147-157
50. 50. Perez-Blas M, Reguerio JR, Ruiz-Contreras JR, Arnaiz-Vilena A (1992) T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway. Clin Exp Immunol 89:83-88
51. 51. Jones JF, Wysocki LJ, Streib J, Hull SP (1992) Possible use of the lymphocyte V gene recombinational system by EBV to achieve its own rearrangements. Proc 5th Int Symp Epstein-Barr Virus and Associated Diseases, Sept. 13-19, p 121
52. 52. Srinivas S, Sixbey JW (1995) Epstein-Barr virus induction of recombinase activating genes RAG-1 and RAG-2. J Virol 69:8155-8158
53. 53. Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD (1995) Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus bearing B cells. Blood 85:1289-1299
54. 54. Rabbitts TH, Boehm T, Mengl-Gaw L (1988) Chromosomal abnormalities in lymphoid tumors: mechanism and role in tumor pathogenesis. Trends Genet 4:300-304
55. 55. Bories JC, Cayuela JM, Loiseau P, Sigaux F (1991) Expression of human recombination activating genes (RAG1 and RAG2) in neoplastic lymphoid cells: correlation with cell differentiation and antigen receptor expression. Blood 78:2053-2061
56. 56. Marolleau J, Fondell J, Malissen M, Trucy J, Barbier E, Marcu K, Cazenave P, Primi D (1988) The joining of germline Vα to Jα genes replaces the pre-existing Vα-Jα complexes in a T cell receptor αβ positive T cell line. Cell 55:291-300
57. 57. Fondell J, Marolleau J, Primi D, Marcu K (1990) On the mechanism of non allelically excluded Vα-Jα T cell receptor secondary rearrangements in a murine T cell lymphoma. J Immunol 144:1094-1103
58. 58. Tein HF, Su IJ, Chuang SM, Lee FY, Liu MC, Tsai TF, Lin KH, Chen RL (1993) Cytogenetic characterisation of Epstein-Barr virus-associated T-cell malignancies. Cancer Genet Cytogen 69:25-30
59. 59. Carey M, Koman J, Katz DA, Gradoville L, Barberis L, Miller G (1992) Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA. J Virol 66:4803-4813
60. 60. Parrel PJ, Rowe DT, Rooney C, Kouzarides T (1989) Epstein-Barr virus BZLF-1 transactivator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J 8:127-132
61. 61. Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD (1990) The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol 64:1143-1155
62. 62. Bos TJ, Monteclaro FS, Mitsunobi F, Ball AR, Chang CHW, Nishimura T, Vogt PK (1990) Efficient transformation of chicken embryo fibroblasts by c-jun requires structural modification in coding and non coding sequences. Genes Dev 4:1677-1687
63. 63. Zhang Q, Gutsch D, Kenney S (1994) Functional and physical interaction between p53 and BZLF-1: implications for Epstein-Barr virus latency. Mol Cell Biol 14:1929-1938
64. 64. Gutsch D, Holley-Guthrie E, Zhang Q, Stein B, Blanar MA, Baldwin A, Kenney SC (1994) The b-ZIP transactivator of Epstein-Barr virus, BZLF-1, functionally and physically interacts with the p65 subunit of NF-kB. Mol Cell Biol 14:1939-1958
65. 65. Sista ND, Barry C, Sampson K, Pagano J (1995) Physical and functional interaction of the Epstein-Barr virus BZLF-1 transactivator with the retinoic acid receptors RARα and RXRα. Nucl Acid Res 23:1729-1736
66. 66. Cayrol C, Flemington EK (1995) Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor βIGH3 (TGF-bIGH3) and TGF-β1. J Virol 69:4206-4212
67. 67. Shull M, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin R, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata, Doetschman (1992) Targeted disruption of the mouse transforming growth factor beta 1 gene results in multifocal inflammatory disease. Nature 359:693-699
68. 68. Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, Yanaguchi N (1992) Apoptotic cell death of primed CD45RO + T lymphocytes in Epstein-Barr virus induced infectious mononucleosis. Blood 80:452-458
69. 69. Minarovits J, Hu LF, Imai S, Harguchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G (1994) Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric lymphomas. J Gen Virol 75:77-84